Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Parapharma Tech is a healthcare company specializing in the development of organic and natural thickening agents for individuals with swallowing difficulties. The company's flagship products, Gelmix and Purathick, are designed to manage conditions such as dysphagia and gastroesophageal reflux in both pediatric and adult populations. Gelmix is notably the first USDA organic thickener for breast milk and infant formula, providing a hypoallergenic alternative to traditional starch-based thickeners. Parapharma Tech focuses on improving the safety and efficacy of feeding for patients requiring thickened liquids. Their products are widely utilized in clinical settings and are recommended by speech-language pathologists and pediatricians. The company is headquartered in Florida and maintains a strong focus on clean-label, allergen-free medical food solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Parapharma Tech.